Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Casaubon who wrote (14740)	12/17/2004 2:58:06 PM
From: zeta1961	Read Replies (2) \| Respond to of 52153

<this has to be treated as a class effect given the circumstances>> Suppressing the urge to be Zeta sarcastic<g> There would be NO drugs on the market if a dose limit was not placed on the label.. The cox-2's, we now know were incorrectly perceived by physicians and patients alike as safe and if a little helps, more helps even more..I too confess to dosing above the label..preload increased<g> I shoulda' written to NEJM providing anecdotal evidence..maybe I'd be famous now for calling it early..shux, couldn't suppress the urge..<g> Tell me you're a class action lawyer and I'll really show no mercy! Jeff was placed on 800mg/day..but he was young, on decadron and hard to differentiate what was causing what.. IMHO, Tylenol is more dangerous as an OTC than these coxibs...do you know how many deaths/hospitalizations occur on an annual basis for non-suicidal intended overdoses? Zeta